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Genome-wide association studies (GWASs) have identified loci for erythrocyte traits in primarily European ancestry populations. We
conducted GWAS meta-analyses of six erythrocyte traits in 71,638 individuals from European, East Asian, and African ancestries using
a Bayesian approach to account for heterogeneity in allelic effects and variation in the structure of linkage disequilibrium between eth-
nicities. We identified seven loci for erythrocyte traits including a locus (RBPMS/GTF2E2) associated with mean corpuscular hemoglobin
andmean corpuscular volume. Statistical fine-mapping at this locus pointed to RBPMS at this locus and excluded nearby GTF2E2. Using
zebrafishmorpholino to evaluate loss of function, we observed a strong in vivo erythropoietic effect for RBPMS but not for GTF2E2, sup-
porting the statistical fine-mapping at this locus and demonstrating that RBPMS is a regulator of erythropoiesis. Our findings show the
utility of trans-ethnic GWASs for discovery and characterization of genetic loci influencing hematologic traits.Introduction
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allele frequencies, and differences in linkage disequilib-
rium (LD) between ethnicities are accounted for. Trans-
ethnic meta-analysis can also enable fine-mapping of
association intervals by evaluating differences in LD struc-
ture between diverse populations, thereby enhancing the
detection of causal variants.13
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cohorts is provided in Table S1 and has been reported previ-
ously.8,11,12,14,15 We conducted replication analyses of the
identified trait-loci associations in six independent studies: the
Gutenberg Health Study (GHS cohorts 1 and 2, both EUR
ancestry), the Genes and Blood-Clotting Study (GBC, EUR
ancestry), the NEO study (EUR ancestry), the JUPITER trial
(EUR ancestry), and the HANDLS study (AFR ancestry)16–21 (total
replication size N ¼ 16,389).Erythrocyte Phenotype Modeling
We analyzed six erythrocyte traits: hemoglobin concentration
(Hb, g/dL), hematocrit (Hct, percentage), mean corpuscular he-
moglobin (MCH, picograms), mean corpuscular hemoglobin
concentration (MCHC, g/dL), mean corpuscular volume (MCV,
femtoliters), and red blood cell count (RBC, 1M cells/cm3). Trait
units were harmonized across all studies. MCH, MCHC, MCV,
and RBC were transformed to obtain normal distributions.
We excluded samples deviating more than 3 SD from the
ethnic- and trait-specific mean within each contributing study,
because we focused on determinants of variation in the general
population rather than on specific hematological diseases
that are overrepresented at the extremes of the trait distribution
(Table S2).Genotyping
In brief, the cohorts comprise unrelated individuals, except for
the Framingham Heart Study (related individuals of European
ancestry) and GeneSTAR (related individuals of European or Afri-
can ancestry). SNPs with a minor allele frequency < 1%, missing-
ness > 5, or HWE p < 107 were excluded. Genotypes were
imputed to approximately 2.5 million SNPs using HapMap
Phase II CEU. The RIKEN and the BioBank Japan Project and
AGEN cohorts comprise unrelated individuals of East Asian
ancestry (EAS). SNPs with a minor allele frequency < 0.01, miss-
ingness > 1%, or HWE p < 107 were excluded. Individuals with
a call rate < 98% were excluded as well. Genotypes were imputed
to approximately 2.5 million SNPs using HapMap Phase II JPT and
CHB. The COGENT consortium cohorts comprise individuals of
African American ancestry (AFR). SNPs with a minor allele fre-
quency < 1% or missingness > 10% were excluded. Genotypes
were imputed to approximately 2.5 million SNPs using HapMap
Phase II CEU and YRI.Cohort-Specific GWASs
For the initial GWA analyses, each cohort used linear regression to
assess the association of all SNPs meeting the quality control
criteria with each of the six traits separately. An additive genetic
model was used and the regressions were adjusted for age, sex,
and study site (if applicable). The Framingham Heart Study and
the GeneSTAR study used linear mixed effects models to account
for relatedness, and these models included adjustment for prin-
cipal components.Ethnic-Specific GWAS Meta-analyses
GWAS results of SNPs with a minor allele frequency (MAF)R 1%
and an imputation quality > 30% were analyzed in a fixed-effect
meta-analysis (METAL software22) within each ancestry group,
with genomic control (GC) correction of the individual GWAS
results of each contributing cohort and the final meta-analysis
results.23The AmTrans-ethnic Meta-analyses
For the trans-ethnic meta-analyses, the three sets of the ethnic-
specific meta-analysis summary statistics were then combined
with three approaches. First, we performed for each trait a trans-
ethnic fixed-effect inverse variance-weighted meta-analysis of
the EUR, EAS, and AFR GWAS summary statistics using METAL.
Second, the ethnic-specific GWAS summary statistics were also
combined using the MANTRA (Meta-Analysis of Trans-ethnic
Association Studies) package, a meta-analysis software tool allow-
ing for heterogeneity in allelic effects due to differences in LD
structure in different ancestry clusters.24 MANTRA results are re-
ported as log10 Bayes’s factors (log10BF). Finally, the three sets of
ethnic-specific results were analyzed by means of the Han and
Eskin RE2 model, a meta-analysis method developed for higher
statistical power under heterogeneity.25 We used the METASOFT
3.0c tool as developed by the Buhm Han laboratories (Web
Resources). For the fixed-effects and the RE2 models, we applied
a genome-wide significance threshold adjusted for multiple
testing, as we analyzed six traits in our study. Given that the traits
under investigation are correlated (Table S10), we used eigenvalues
to assess the effective number of independent traits according to Ji
and Li,26 and we estimated this number at 4.0549 using theMatrix
Spectral Decomposition tool (Web Resources). We therefore
considered p values smaller than 1.25 3 108 (i.e., 5 3 108 /
4.0549) as genome-wide significant. For the MANTRA discovery
analyses, a log10BF > 6.1 was considered as a genome-wide signif-
icant threshold value.27Replication in Human Cohorts
The six independent replication studies—the Gutenberg Health
Study (GHS cohorts 1 and 2, both EUR ancestry), the Genes and
Blood-Clotting Study (GBC, EUR ancestry), the NEO study (EUR
ancestry), the JUPITER trial (EUR ancestry), and the HANDLS
study (AFR ancestry)16–21 (total replication size N ¼ 16,389)—pro-
vided linear regression results for the nine trait-locus combina-
tions. Their results were meta-analyzed with a fixed effects inverse
variance weighted method (METAL) and the RE2 methodology.
Additionally, wemeta-analyzed replication results with the discov-
ery data using fixed-effects, MANTRA, and RE2 methods. For the
replication analyses of the nine individual trait-locus combina-
tions, we applied a threshold of p < 0.05/9. Additional human
replication findings are provided in Supplemental Data.Fine-Mapping
We used the MANTRA results to fine-map the regions of trait-asso-
ciated index SNPs. We defined regions by identifying variants
within a 1 Mb window around each index SNP (500 kb upstream
and 500 kb downstream). For each SNP in a region, the posterior
probability that this SNP is driving the region’s association signal
was calculated by dividing the SNP’s BF by the summation of the
BFs of all SNPs in the region. Credible sets (CSs) were subsequently
created by sorting the SNPs in each region in descending order
based on their BF (starting with the index SNP since this SNP
has the region’s largest BF by definition). Going down the sorted
list, the SNPs’ posterior probabilities were summed until the cu-
mulative value exceeded 99% of the total cumulative posterior
probability for all SNPs in the region. The length of a CS was ex-
pressed in base pairs. We compared 99% CSs for the trans-ethnic
results and the results of a EUR-only MANTRA analysis.13,24,28
For theMANTRA fine-mapping analyses, a less stringent threshold
value of log10BF > 5 was applied, because we wanted to includeerican Journal of Human Genetics 100, 51–63, January 5, 2017 53
previously identified regions that may not have showed up in the
more stringent MANTRA discovery analyses.Heterogeneity Analysis
Heterogeneity of the associations across the different ethnicities
was assessed by the I2 and Cochran’s Q statistics as reported by
METAL22 and the posterior probability of heterogeneity as re-
ported by MANTRA.24ENCODE Annotation
We evaluated the SNPs identified in the discovery analyses against
the ENCODE Project Consortium’s database of functional ele-
ments in the K562 erythroleukemic line.29Experiments in Zebrafish
To substantiate the fine mapping of the RBPMS/GTF2E2 region
biologically, we tested the effect of morpholino knockdown in
zebrafish for both RBPMS and GTF2E2 orthologous genes, fol-
lowed by assays of erythrocyte development.
Zebrafish rbpms, rbpms2, and gtf2e2 were identified and
confirmed by peptide sequence homology study and gene synteny
analysis. For rbpms, we relied solely on peptide homology compar-
ison and domain structure since no syntenic regionwas previously
annotated and found by this study.
For eachmorpholino (MO), its design incorporated information
about gene structure and translational initiation sites (Gene-Tool
Inc.). MOs targeting each transcript were injected into single-cell
embryos at 1, 3, and 5 ng/embryo to find an optimal dose at which
there was minimal non-specific toxicity. The stepwise doses also
give a range of phenotypes from a hypomorph to a near complete
knockdown for most transcripts, which were used to assess the ad-
ditive model of genetic association. After injection, embryos were
collected at specified time points, 16–18 ss, 22–26 hpf, and 48 hpf
using both standard morphological features of the whole embryo
and hours post-fertilization (hpf) to minimize differences in em-
bryonic development staging caused by the MO injection.30,31
The embryos were then assayed for hematopoietic development
by whole-mount in situ hybridization and benzidine staining.
We conducted two assays simultaneously for globin transcription
and hemoglobin formation. For the globin transcription, devel-
oping erythrocytes in the intermediate cell mass of the embryos
were assayed by embryonic b-globin 3 expression at the 16 somite
stage, or 16–18 hpf.31 Benzidine staining phenotype was catego-
rized from subtle decrease to complete absence of staining, which
was categorized as mild, intermediate, or strong effect. Morpho-
logically normal morphants with decreased blood formation
were scored for hematopoietic effect.
In zebrafish, rbpms was not annotated in the known EST and
cDNA databases, although a genomic sequence in the telomeric re-
gion on chromosome 7 predicting a coding sequence (80% pep-
tide sequence similarity) was identified. In addition, the synteny
between human RBPMS and GTF2E2 is not conserved in zebrafish
where rbpms and gtf2e2 are located on two separate chromosomes,
chromosomes 7 and 1, respectively. rbpms2 was annotated with
two paralogs on chromosome 7 (26 Mb away from and centro-
meric to the true rbpms) and chromosome 25 of the zebrafish
genome. This orthology mapping was confirmed again by this
research based on gene synteny and 88% and 91% sequence sim-
ilarity, respectively, for rbpms2b and rbpms2a to human RBPMS2.
These two zebrafish RBPMS2 orthologs have a higher overall
sequence similarity to human RBPMS than the true zebrafish54 The American Journal of Human Genetics 100, 51–63, January 5, 2rbpms, but both have a RBPMS2-signature stretch of alanine in
the C terminus of the protein. Therefore, to confirm our rbpms
orthology study and to confirm functional conservation of rbpms
in zebrafish, MO individual knockdown of both rbpms2a and
rbpms2b was also performed in independent experiments,
showingmuch less or no effect by rbpms2a knock-down andmod-
erate effect by rbpms2b impact on erythropoiesis, suggesting func-
tional compensation of the genes in the rbpms family in zebrafish
during embryonic erythropoiesis.Chromatin Immunoprecipitation and Assay for
Transposase Accessible Chromatin in Human CD34þ
Cell Lines
For ChIP-seq experiments, the following antibodies were used:
Gata1 (Santa Cruz cat# sc265X), Gata2 (Santa Cruz cat#
sc9008X), and H3K27ac (Abcam cat# ab4729; RRID: AB_
2118291). ChIP experiments were performed as previously
described with slight modifications.32,33 In brief, 20–30 million
cells for each ChIP were crosslinked by the addition of 1/10 vol-
ume 11% fresh formaldehyde for 10 min at room temperature.
The crosslinking was quenched by the addition of 1/20 volume
2.5 M glycine. Cells were washed twice with ice-cold PBS and
the pellet was flash-frozen in liquid nitrogen. Cells were kept
at 80C until the experiments were performed. Cells were lysed
in 10 mL of lysis buffer 1 (50 mM HEPES-KOH [pH 7.5],
140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 0.25%
Triton X-100, and protease inhibitors) for 10 min at 4C. After
centrifugation, cells were resuspended in 10 mL of lysis buffer 2
(10 mM Tris-HCl [pH 8.0], 200 mM NaCl, 1 mM EDTA, 0.5 mM
EGTA, and protease inhibitors) for 10 min at room temperature.
Cells were pelleted and resuspended in 3 mL of sonication buffer
for K562 and U937 and 1 mL for other cells used (10 mM Tris-
HCl [pH 8.0], 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1%
Na-Deoxycholate, 0.05% Nlauroylsarcosine, and protease inhibi-
tors) and sonicated in a Bioruptor sonicator for 24–40 cycles of
30 s followed by 1 min resting intervals. Samples were centrifuged
for 10 min at 18,000 3 g and 1% of TritonX was added to the su-
pernatant. Prior to the immunoprecipitation, 50 mL of protein G
beads (Invitrogen 100-04D) for each reaction were washed twice
with PBS, 0.5% BSA. Finally, the beads were resuspended in
250 mL of PBS, 0.5% BSA, and 5 mg of each antibody. Beads
were rotated for at least 6 hr at 40C and then washed twice
with PBS, 0.5% BSA. Cell lysates were added to the beads and incu-
bated at 40C overnight. Beads were washed 13 with 20 mM Tris-
HCl (pH 8), 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton
X-100, 13 with 20 mM Tris-HCl (pH 8), 500 mM NaCl, 2 mM
EDTA, 0.1% SDS, 1% Triton X-100, 13 with 10 mM Tris-HCl
(pH 8), 250 nM LiCl, 2 mM EDTA, 1% NP40, and 13 with TE
and finally resuspended in 200 mL elution buffer (50 mM Tris-
HCl [pH 8.0], 10 mM EDTA, and 0.5%–1% SDS). 50 mL of cell
lysates prior to addition to the beads was kept as input. Crosslink-
ing was reversed by incubating samples at 65C for at least 6 hr.
Afterward the cells were treated with RNase and proteinase K
and the DNA was extracted by phenol/chloroform extraction.
ChIP-seq libraries were prepared using the following protocol.
End repair of immunoprecipitated DNA was performed using the
End-It DNA End-Repair kit (Epicenter, ER81050) and incubating
the samples at 25C for 45min. End-repaired DNAwas purified us-
ing AMPure XP Beads (1.83 the reaction volume) (Agencourt
AMPure XP – PCR purification Beads, BeckmanCoulter, A63881)
and separating beads using DynaMag-96 Side Skirted Magnet017
(Life Technologies, 12027). A tail was added to the end-repaired
DNA using NEB Klenow Fragment Enzyme (30-50 exo, M0212L),
13 NEB buffer 2, and 0.2 mM dATP (Invitrogen, 18252-015) and
incubating the reaction mix at 37C for 30 min. A-tailed DNA
was cleaned up using AMPure beads (1.83 reaction volume). Sub-
sequently, cleaned-up dA-tailed DNA went through Adaptor liga-
tion reaction using Quick Ligation Kit (NEB, M2200L) according
to the manufacturer’s protocol. Adaptor-ligated DNA was first
cleaned up using AMPure beads (1.83 of reaction volume), eluted
in 100 mL and then size-selected using AMPure beads (0.93 of the
final supernatant volume, 90 mL). Adaptor ligated DNA fragments
of proper size were enriched with PCR reaction using Fusion High-
Fidelity PCR Master Mix kit (NEB, M0531S) and specific index
primers supplied in NEBNext Multiplex Oligo Kit for Illumina
(Index Primer Set 1, NEB, E7335L). Conditions for PCR used are
as follows: 98C, 30 s; (98C, 10 s; 65C, 30 s; 72C, 30 s) 3 15
to 18 cycles; 72C, 5 min; hold at 4C. PCR-enriched fragments
were further size selected by running the PCR reaction mix in
2% low-molecular-weight agarose gel (Bio-Rad, 161-3107) and
subsequently purifying them using QIAquick Gel Extraction Kit
(28704). Libraries were eluted in 25 mL elution buffer. After
measuring concentration in Qubit, all the libraries went through
quality-control analysis using an Agilent Bioanalyzer. Samples
with proper size (250–300 bp) were selected for next generation
sequencing using Illumina Hiseq 2000 or 2500 platform.
Alignment and visualization ChIP-seq reads were aligned to the
human reference genome (hg19) using bowtie with parameters -k
2 -m 2 -S.34 WIG files for display were created using MACS35 with
parameters -w -S–space ¼ 50–nomodel–shiftsize ¼ 200 and were
displayed in IGV.36,37
High-confidence peaks of ChIP-seq signal were identified using
MACS with parameters–keepdup ¼ auto -p 1e-9 and correspond-
ing input control. Bound genes are RefSeq genes that contact
a MACS-defined peak between 10,000 bp from the TSS
and þ5,000 bp from the TES.
For the assay for transposase accessible chromatin (ATAC-seq),
CD34þ cells were expanded and differentiated using the protocol
mentioned above. Before collection, cells were treated with
25 ng/mL hrBMP4 for 2 hr. 5 3 104 cells per differentiation stage
were harvested by spinning at 500 3 g for 5 min, 4C. Cells were
washed once with 50 mL of cold 13 PBS and spun down at
500 3 g for 5 min, 4C. After discarding supernatant, cells were
lysed using 50 mL cold lysis buffer (10 mM Tris-HCl [pH 7.4],
10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-360) and spun
down immediately at 500 3 g for 10 min, 4C. The cells were
then precipitated and kept on ice and subsequently resuspended
in 25 mL 2X TD Buffer (Illumina Nextera kit), 2.5 mL transposase
enzyme (Illumina Nextera kit, 15028252), and 22.5 mL nuclease-
free water in a total of 50 mL reaction for 1 hr at 37C. DNA was
then purified using QIAGEN MinElute PCR purification kit
(28004) in a final volume of 10 mL. Libraries were constructed
according to Illumina protocol using the DNA treated with trans-
posase, NEB PCR master mix, Sybr green, and universal and li-
brary-specific Nextera index primers. The first round of PCR was
performed under the following conditions: 72C, 5 min; 98C,
30 s; (98C, 10 s; 63C, 30 s; 72C, 1 min) 3 5 cycles; hold at
4C. Reactions were kept on ice and, using a 5 mL reaction aliquot,
the appropriate number of additional cycles required for further
amplification was determined in a side qPCR reaction: 98C,
30 s; (98C, 10 s; 63C, 30 s; 72C, 1 min) 3 20 cycles; hold at
4C. Upon determining the additional number of PCR cycles
required further for each sample, library amplification was con-The Amducted using the following conditions: 98C, 30 s; (98C,10 s;
63C, 30 s; 72C, 1 min) 3 appropriate number of cycles; hold
at 4C. Libraries prepared went through quality-control analysis
using an Agilent Bioanalyzer. Samples with appropriate nucleo-
somal laddering profiles were selected for next generation
sequencing using Illumina Hiseq 2500 platform.
All human ChIP-seq datasets were aligned to build version
NCBI37/HG19 of the human genome using Bowtie2 (v.2.2.1)34
with the following parameters:–end-to-end, -N0, -L20. We used
the MACS2 v.2.1.035 peak finding algorithm to identify regions
of ATAC-seq peaks, with the following parameter: –nomodel–
shift 100–extsize 200. A q-value threshold of enrichment of
0.05 was used for all datasets.Evaluation in Mouse Crosses
To further affirm the trait loci we identified, and in an attempt to
further fine-map the intervals identified in our discovery analyses
through cross-species comparisons, we evaluated the new loci in
syntenic regions in 12 inter-strain mouse QTL crosses.38
In brief, mice from 12 different strains were inter-crossed38 and
the same erythrocyte traits we have studied by GWAS were
measured in peripheral blood. The Jackson Laboratory Animal
Care and Use Committee approved all protocols. The number of
markers genotyped per cross varied by the platform used, and the
totalnumberper cross is provided inTable S9.QTLanalysiswasper-
formed for each erythrocyte trait using R/qtl v1.07-12 (Web Re-
sources).39 Geneticmap positions of all markers usedwere updated
to the new mouse genetic map using online mouse map converter
tool (Web Resources).40 All phenotypic data were ranked-Z trans-
formed to approximate the normal distribution prior to analysis.
The QTL analysis was performed as a genome-wide scan with sex
as an additive covariate. Permutation testing (1,000 permutations)
was used to determine significance, and LOD scores greater than
the 95th percentile (p< 0.05)were considered significant. QTL con-
fidence intervals were determined by the posterior probability.41,42
For each candidate region in the mouse, the coordinates were ob-
tained from the Mouse Genome Database, which is part of Mouse
Genome Informatics (MGI), using the ‘‘Genes and Markers’’ query
(Web Resources). Protein coding genes, non-coding RNA genes,
and unclassified genes were queried.Results
In this study we analyzed the association of genetic varia-
tion in 71,638 individuals and 6 clinically relevant eryth-
rocyte traits which are commonly measured, accounting
for the diverse ethnic background of the participants.
We identified 44 previously reported loci7–12,43–47 (Table
S3) and 9 other significant trait-locus associations at 7 loci
(p < 5 3 108 or log10BF > 6.1, Table 1). SHROOM3 was
simultaneously identified in an exome chip analysis by
our group in overlapping samples.48 Ethnic-specific results
are presented in Table S4. Regional association plots are
shown for each region in Figure S1, showing ethnic-spe-
cific results, the trans-ethnic meta-analysis, and plots of
pairwise LD across the regions for EUR, EAS, and AFR
ancestry.
Five of the discovered trait loci showed a significant asso-
ciation in the fixed-effects trans-ethnic METAL analyses, inerican Journal of Human Genetics 100, 51–63, January 5, 2017 55
Table 1. Findings from the METAL and MANTRA Trans-ethnic Analyses
Trait SNP Chr Gene c/nc N
METAL MANTRA RE2
Effect (SE) p Log10BF posthg p
Hb rs2299433 7 MET T/C 63,091 0.041 (0.008) 6.16 3 108 6.195 0.027 1.20 3 107
Hct rs6430549 2 TMEM163 / ACMSD A/G 71,647 0.103 (0.018) 4.96 3 109 7.408 0.120 8.46 3 109
Hct rs2299433 7 MET T/C 63,532 0.102 (0.019) 5.66 3 108 6.199 0.099 9.87 3 108
MCH rs2060597 3 PLCL2 T/C 38,836 0.006 (0.001) 4.18 3 1010 8.178 0.009 9.75 3 1010
MCH rs2979489 8 RBPMS A/G 37,531 0.002 (0.001) 8.89 3 105 9.723 1.000 1.19 3 1012
MCV rs10929547 2 ID2 A/C 50,870 0.002 (0.0003) 2.50 3 109 7.977 0.007 2.14 3 109
MCV rs9821630 3 PLCL2 A/G 48,697 0.002 (0.0004) 6.86 3 109 7.864 0.004 2.44 3 109
MCV rs2979489 8 RBPMS A/G 48,697 0.002 (0.0004) 7.24 3 109 7.961 0.003 1.65 3 109
MCV rs6121246 20 FOXS1 T/C 49,896 0.003 (0.001) 4.05 3 107 6.296 0.003 8.31 3 108
Abbreviations are as follows: chr, chromosome number; c/nc, coding/non-coding allele; n, number of participants; SE, standard error; p, p value; log10BF, log-
arithm of Bayes Factor; posthg, posterior probability of heterogeneity.the Bayesian MANTRA analyses, and in the RE2 analyses;
these were TMEM163/ACMSD for Hct, PLCL2:rs2060597
for MCH, and ID2, PLCL2:rs9821630, and RBPMS for
MCV. Two loci (MET and FOXS1) showed a borderline sig-
nificant effect in METAL and RE2 and a strong significant
effect in MANTRA for HB and MCV, respectively. The asso-
ciation of rs2979489 (RBPMS) further showed a strong
association with MCH in the multi-ethnic Bayesian
meta-analysis and in the RE2 model but was not detected
in the multi-ethnic fixed-effects meta-analysis, nor in any
of the ethnic-specific meta-analyses for this trait. Interest-
ingly, MCH and MCV are correlated traits, yet strong het-
erogeneity of effect was observed for this SNP’s association
with MCH only, as indicated by both METAL (I2 statistic
94%, p value Cochran’s Q statistic of heterogeneity
6.48 3 108) and MANTRA (posterior probability of het-
erogeneity ¼ 1) (Table 1). Inspection of the discovery data-
sets showed that one of the African American cohorts
supplied data for MCV but not for MCH, which resulted
in a stronger positive association of rs2979489 with MCH
than with MCV in the AFR meta-analyses. This phenome-
non was accompanied by greater evidence of heterogene-
ity for MCH in the trans-ethnic meta-analyses because
the EUR and EAS associations were in the opposite direc-
tion to that observed in the AFR meta-analysis. The
MANTRA and RE2 analyses were able to account for this
heterogeneity and thus yield a stronger result as compared
to METAL for this trait locus.Replication Analyses
In the meta-analyses of the replication cohorts, the trait-
SNP combinations HT-TMEM163/ACMSD and MCH-
RBPMS achieved a Bonferroni-corrected significance
threshold with both fixed effects and RE2 methods
(p < 0.05/9). ID2 was Bonferroni-significant in the fixed-
effects model and nominally significant in the RE2 model.
Furthermore, we found nominal significance for MCV-56 The American Journal of Human Genetics 100, 51–63, January 5, 2RBPMS (fixed-effects analyses) and FOXS1 (fixed-effects
and RE2) (Table S5).
When we compared the discovery and replication com-
bined meta-analyses with the discovery analyses alone, we
observed stronger associations for Hct-TMEM163/ACMSD,
MCH-PLCL2, MCV-ID2, and MCV-RBPMS in all three
models (fixed-effects, MANTRA, and RE2). For MCH-
RBPMS, we found a stronger association in the fixed-effects
analysis (Table S6).Statistical Fine-Mapping
We found that 31 trait-specific trans-ethnic 99% CSs
showed a decrease in length of at least 50% as compared
to their EUR-only CS counterparts (26 unique loci across
the 6 erythrocyte traits) (Table S7).
Among the loci identified in this study, the chromosome
8 RBPMS locus showed fine-mapping according to this cri-
terion (Table 2, Figure 1). For MCH, the EUR credible set
spanned 204,200 bp, encompassing RBPMS and GTF2E2.
The multi-ethnic credible set comprised just one SNP,
rs2979489, within the first intron of RBPMS (Figure 1).
Remarkably, this associated SNP rs2979489 is located adja-
cent to a GATA-motif where a gradual switch of binding
from GATA2 to GATA1 takes place during commitment
of human CD34 progenitors toward erythroid lineage
(Figure 2, bottom left). Moreover, an assay for chromatin
accessibility sites (ATAC-seq) and H3K27a ChIP-seq clearly
identify that the genomic region proximal to this SNP is
actively regulated during human erythroid differentiation
(Figure 2, bottom right).
Among the known loci, fine mapping narrowed signals
as shown in Table S7.
Interestingly, trans-ethnic fine-mapping of the XRN1 lo-
cus (MCH) led us to the rs6791816 polymorphism. Van der
Harst et al. identified the same SNP in their exploration of
nucleosome-depleted regions (NDRs, representing active
regulatory elements for erythropoeisis) in a follow-up017
Table 2. Fine Mapping of a Chromosome 8 Locus Identified in European Ancestry Meta-analysis by MANTRA Trans-ethnic Analysis
Trait Chr Gene
EUR Multi-ethnic
topSNP log10BF n_SNPs width (bp) topSNP log10BF n_SNPs width (bp)
MCH 8 RBPMS rs2979502 6.32982 21 241480 rs2979489 9.72267 1 1
MCV 8 RBPMS rs2979489 6.13733 11 241480 rs2979489 7.96132 1 1
Abbreviations are as follows: chr, chromosome number; log10BF, logarithm of Bayes Factor; n_SNPs, number of SNPs in the region.analysis of their GWAS results.10 By means of subsequent
formaldehyde-assisted isolation of regulatory elements fol-
lowed by next-generation sequencing (FAIRE-seq), they
pinpointed rs6791816 as an NDR SNP in LD with their
initial index SNP for MCH and MCV.
Furthermore, fine-mapping of both the MPND locus
(MCH) and SH3GL1 locus (MCV) pointed to the rs8887
SNP within the 30 UTR of PLIN4. The rs8887 SNP minor
allele has been shown experimentally to create a novel
seed site for miR-522, resulting in decreased PLIN4 expres-
sion.49 miR-522 is expressed in circulating blood,50 and
these data suggest that an allele-specific miR-522 regula-
tion of PLIN4 by rs8887 could serve as a functional mech-
anism underlying the identified association.
We additionally showed fine mapping in several other
intervals (Table S7) with fine-mapped genes about whichFigure 1. Fine Mapping of the Chromosome 8 RBPMS/GTF2E2 Loc
99% credible sets (red dots) around the top hit rs2979489 (red diamon
MCV (right) are shown, compared to 99% credible sets of the trans-et
right).
The Amless is known about their potential biologic role in erythro-
poeisis or red blood cell function. These regions are of in-
terest for further hypothesis generation based upon the
GWAS findings.
ENCODE Analyses
We further evaluated the SNPs from the chromosome 8
RBPMS region against the ENCODE Project Consortium’s
database of numerous functional elements in the K562
erythroleukemic line.29 The lone SNP that was fine map-
ped at the locus, rs2979489, was found in a strong
enhancer element as defined by Segway, supporting a func-
tional role for this SNP and RBPMS. The other SNPs in the
RBPMS region, excluded by the statistical fine-mapping ex-
ercise, were not annotated as regulatory in the ENCODE
data (Table S8).us
d). European Ancestry MANTRA analyses (top) for MCH (left) and
hnic MANTRA analyses (bottom,MCH on the left andMCVon the
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Figure 2. rs2979489 Is Localized to a Po-
tential Regulatory Site that Involves Tran-
sition Binding of GATA2 to GATA1 during
Erythrocyte Differentiation
Top shows gene-track view of rs2979489
location in the RBPMS/GTF2E2 gene re-
gion. Bottom left: gene track of RBPMS
gene showing overlap of GATA2, GATA1,
and ATAC-seq peaks (red, blue, and green,
respectively) during human erythroid
differentiation. Bottom right: overlap of
ATAC-seq (green) and H3K27ac ChIP-seq
(black) during differentiation at the region
proximal to the SNP rs2979489. The gray
horizontal line indicates the position of
SNP rs 2979489. D0, day 0; H6, hour 6;
D3, day 3; D4, day 4; and D5, day 5 of
erythroid differentiation time-course post-
induction of differentiation.Experiments in Zebrafish
We identified a erythropoietic effect for the zebrafish
rbpms. Both embryonic globin expression at 16 ss and o-di-
anisidine/benzidine staining at 48 hpf significantly
decreased in morphants, indicating a decrease in both
globin transcription and Hb levels (Figure 3). This loss-of-
function finding is consistent with a decreased mean
erythrocyte Hb content observed in our human associa-
tion results. In zebrafish, the rbpms orthology mapping
included rbpms2a, rbpms2b, and rbpms, and loss-of-func-
tion phenotypes of all orthologs were tested experimen-
tally. The results suggested a clear erythropoietic effect
with limited functional compensation of the genes in the
rbpms family in zebrafish during embryonic erythropoi-
esis. On the other hand, morpholino knockdown experi-
ments with the zebrafish ortholog of GTF2E2 did not
show an apparent erythropoietic effect.
Review of the human association results showed no evi-
dence of pleiotropy across the RBPMS family of genes and
denote that the human association is specific to RBPMS
(Supplemental Data). This review was conducted because
the orthology in the fish led to inclusion of rbpms2 in
the zebrafish analyses as well. These findings indicate
that the statistical fine-mapping was useful to home in
on RPBMS as a causal gene influencing erythropoiesis.
Evaluation in Mouse Crosses
In the eight regions from our discovery analysis, six had
evidence of cross-species validation by evidence of syn-
tenic gene within the linkage peak in the mouse QTL re-
sults (Table 3). However, the human GWAS intervals were
not narrowed by the mouse QTL results for any of these
loci (Table S9).58 The American Journal of Human Genetics 100, 51–63, January 5, 2017Discussion
We conducted GWASs and meta-ana-
lyses of six erythrocyte traits (Hb,
Hct, MCH, MCHC, MCV, and RBC)
in 71,638 individuals from European,Asian, and African American ancestry. While prior
genome-wide association studies have identified loci asso-
ciated with erythrocyte traits through the analysis of
ancestrally homogeneous cohorts and consortia, largely
biased toward European ancestry studies, trans-ethnic
analysis has not previously been performed while account-
ing for differences in genetic architecture in ethnically
diverse groups.
We identified seven loci for erythrocyte traits (nine
locus-trait combinations) and replicated 44 previously
identified loci. We fine-mapped several known and new
loci. One fine-mapped locus led us to a region on chromo-
some 8 associated with MCH and MCV.
In the chromosome 8 RBPMS/GTF2E2 locus, the index
variant rs2979489, which was associated with MCV and
MCH and highlighted in the trans-ethnic fine-mapping
analyses, is located within the first intron of RBPMS (RNA
binding protein with multiple splicing), notably at an
open chromatin site at which a switch of GATA1/2 bind-
ing occurs during erythroid differentiation. The RBPMS
protein product regulates a variety of RNA processes,
including pre-mRNA splicing, RNA transport, localization,
translation, and stability.51,52 RBPMS is expressed at rela-
tively low levels in mammalian erythroblasts and the pro-
tein product has not been detected in mature human
erythrocytes.53,54
The rs2979489 polymorphism showed remarkably high
heterogeneity in effect on the MCH trait across the
different ethnicities, with different directions of effect for
the AFR meta-analysis results compared to the EUR and
ASN findings. If the variant is causal, this pattern of associ-
ation could reflect gene-environment interaction. In this
case, different exposures in AFR compared to EUR/ASN
Figure 3. Loss-of-Function Analysis of
the RBPMS, RBPMS2, and GTF2E2 Ortho-
logs in Zebrafish
After injection of 0–3 ng ATG and splicing
morpholinos (MOs) against the RBPMS
zebrafish ortholog (row E), both the o-dia-
nisidine/benzidine staining (arrows) in
embryos at 48 hpf (right) and the embry-
onic be3 globin expression in embryos at
16–18 ss (left) are obviously decreased,
indicating a dose-dependent disruption
in erythropoiesis in the experimentally
treated embryos as compared to uninjected
and gtf2e2-, rbpms2a-, and rbpms2b-MO-in-
jected controls (rows A–D). Representative
results are shown for the embryos injected
with MOs against the RBPMS ortholog in
(E) as well as for the embryos injected
withMOs against rbpms2a (C) and rbpms2b
(D) at higher doses. Injections of MO
against the zebrafish GTF2E2 ortholog (B)
also at a higher dose show no obvious ef-
fect on be3 globin expression at 16–18 ss
and o-dianisidine/benzidine staining at
48 hpf. Expression pattern of vascular
marker gene kdrl (A–E, middle) is relatively
normal in all MO-injected embryos at 24–
26 hpf, suggesting grossly normal develop-
ment of cells in other organs. The numbers
on the lower right corner of each image
indicate the number of embryos with phe-
notypes similar to the ones shown on each
of the images over the total number of em-
bryos examined in each of the experi-
mental groups.populations may lead to a marginal effect of the SNP in
opposing directions by different selection pressures. If,
however, rs2979489 is not causal, but rather a marker in
LD with the causal variant, then the opposing direction
of effects could reflect very different LD structures in the
different populations, also indicating selection, or theoret-
ically it could even reflect different causal variants in AFR
and EUR/EAS—and rs2979489 being just in strong LD
with both causal variants.
The SNP rs2979489 is located adjacent to a GATA-motif
where a gradual switch of binding from GATA2 to GATA1
takes place during commitment of human CD34 progeni-
tors toward erythroid lineage. These observations suggest
that rs2979489 localizes at a potential regulatory site
where a modulation of erythroid cell differentiation occurs
and the presence of rs2979489 may lead to observed red
cell trait alterations in human populations, possibly
through regulation of RBPMS expression timing, level,
and/or splicing variation. Although RBPMS previouslyThe American Journal of Humanhad no known role in hematopoiesis
or more specifically in erythropoiesis,
RBPMS has been previously shown to
be upregulated in transcriptional pro-
files of murine and human hemato-
poietic stem cells.55–57 Its role may
be at much earlier stages during thedifferentiation of erythrocytes from erythroblasts and/or
hematopoietic stem cells. RBPMS is known to physically
interact with Smad2, Smad3, and Smad4 and stimulate
smad-mediated transactivation through enhanced Smad2
and Smad3 phosphorylation and associated promotion
of nuclear accumulation of Smad proteins.58 These Smad
proteins are known to regulate the TGF-b-mediated regula-
tion of hematopoietic cell fate and erythroid differentia-
tion.59 RBPMS has four annotated transcript isoforms,
and further delineation of the tissue specificity, timing of
expression, and function of these transcripts in the context
of the genetic variant we identified warrants further study.
Among the additional six loci, we identified two loci in
which the index SNP was located within annotated genes,
rs6430549 in ACMSD (aminocarboxymuconate semi alde-
hyde decarboxylase, intronic) and rs2299433 in MET
(mesenchymal epithelial transition factor, intronic). No
previous hematologic role has been described for either re-
gion. Variants in the chromosome 2q21.3 ACMSD regionGenetics 100, 51–63, January 5, 2017 59
Table 3. Mouse QTL Validation of the Findings from MANTRA Trans-ethnic Analyses
Trait Chr Gene
Human (hg18/Build 36) Mouse (37 mm9)
Significant and Suggestive
Mouse QTLa
LOD(Chromosome:Position) (Chromosome:Position) Peak (95% CI) (Mb)
Hct 2 TMEM163/ACMSD chr2: 135,196,450–135,438,613 chr1: 129,581,372–129,711,586b 141.0 (54.8–158.9)* 3.72*
Hct 4 SHROOM3 chr4: 77,586,311–77,629,342 chr5: 93,112,461–93,394,344 46.0 (19.6–106.5) 2.34
Hct 7 MET chr7: 116,118,114–116,131,947 chr6: 17,432,318–17,447,418b 37.6 (6.6–127.9) 2.75
MCH 8 RBPMS chr8: 30,400,375–30,400,375 chr8: 34,893,115–35,040,335 78.9 (28.0–96.1)* 3.98*
MCV 3 PLCL2 chr3: 16,860,239–16,945,942 chr17: 50,604,848–50,698,773b 46.0 (28.6–55.3)* 5.46*
MCV 20 FOXS1 chr20: 29,684,484–29,897,013 chr2: 152,576,419–152,758,874b 170.1 (147.6–179.3)* 4.69*
aGene found in a significant (indicated with asterisk) or suggestive 95% CI mouse QTL, not corresponding to the human interval.
bWithin the corresponding human interval (5250 kb).have previously been associated with blood metabolite
levels, obesity, and Parkinson disease.60–62 A genetic
variant in the first intron of MET was significantly associ-
ated with both Hb and Hct; however, association was not
observed in replication samples, possibly due to lower po-
wer in the replication experiment. Three additional loci
were intergenic but close to a coding gene (rs10929547
near ID2 [inhibitor of DNA binding 2, dominant-negative
helix-loop-helix protein], rs6121246 near FOXS1 [forkhead
box S1], and rs2060597 approximately 40 kbp upstream
of PLCL2 [phospholipase C-like 2]). The roles of variants
in these regions in determining erythrocyte traits are
unknown.53,63
In the statistical fine-mapping analyses, the trans-ethnic
meta-analysis approach resulted in smaller 99% credible
intervals in all of the loci identified in this study. Since
these loci were identified in analyses that accounted for
heterogeneity in allelic effects between ethnic groups, in
which the heterogeneity may be due to variation in LD
patterns, we examined the LD patterns in these loci. Not
surprisingly, we noted that the consistent decrease in the
size of 99% credible interval across all loci is likely due to
the inclusion of cohorts of African ancestry, an ethnic
group with generally smaller LD blocks throughout the
genome. The loss-of-function screens in zebrafish for the
chromosome 8 signal suggested that these analyses suc-
cessfully identified a single gene (RBPMS) with erythropoi-
etic effect within one of the fine-mapped intervals. We also
fine-mapped previously known regions such as the chro-
mosome 6p21.1 region associated with RBC count and
highlighted CCND3, which has been experimentally
shown to regulate RBC count experimentally in a knock-
out mouse model.64 These examples suggest that attempts
to refine association signals using these types of ap-
proaches in existing samples may yield functional candi-
dates for further mechanistic hypothesis testing, which is
a major goal of GWASs.
Trans-ethnic genome-wide meta-analyses of common
variants have aided in the characterization of genetic
loci for various complex traits.13,65–67 Our data demon-
strate the benefits of trans-ethnic genome-wide meta-anal-60 The American Journal of Human Genetics 100, 51–63, January 5, 2ysis in identifying and fine-mapping genetic loci of eryth-
rocyte traits. By exploiting the differences in genetic
architecture of the associations within these loci in various
ethnic groups, we may identify causal genes influencing
clinically relevant hematologic traits. Use of a similar
approach for other complex traits is likely to provide
deeper insights into the biological mechanisms underlying
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